Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Ting

Showing results (111-120 of 156) with videos related to

Pageof 16
Sort By:
Nature|August 25, 2016
HER2 expression identifies dynamic functional states within circulating breast cancer cellsNicole Vincent Jordan, Aditya Bardia, Ben S Wittner, et al.
Journal of the National Cancer Institute|June 5, 2020
Tumor Microenvironment Immune Response in Pancreatic Ductal Adenocarcinoma Patients Treated With Neoadjuvant TherapyTheodoros Michelakos, Lei Cai, Vincenzo Villani, et al.
Nature|July 6, 2012
RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasisMin Yu, David T Ting, Shannon L Stott, et al.
Science (New York, N.Y.)|February 8, 2020
Deregulation of ribosomal protein expression and translation promotes breast cancer metastasisRichard Y Ebright, Sooncheol Lee, Ben S Wittner, et al.
Journal for Immunotherapy of Cancer|April 3, 2026
TROP2/claudin program mediates immune exclusion to impede checkpoint blockade in breast cancerBogang Wu, Win Thant, Elena Bitman, et al.
Nature Communications|February 10, 2017
Expression of β-globin by cancer cells promotes cell survival during blood-borne disseminationYu Zheng, David T Miyamoto, Ben S Wittner, et al.
Nature|April 15, 2026
Author Correction: HER2 expression identifies dynamic functional states within circulating breast cancer cellsNicole Vincent Jordan, Aditya Bardia, Ben S Wittner, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2026
Dynamic monitoring of antibody drug conjugates targeting TROP2 or HER2 in breast cancer using circulating tumor cellsAvanish Mishra, Rachel O Abelman, Quinn Cunneely, et al.
Cancer Research|January 20, 2022
Differential Kinase Activity Across Prostate Tumor Compartments Defines Sensitivity to Target InhibitionNezihi Murat Karabacak, Yu Zheng, Taronish D Dubash, et al.
JCI Insight|May 5, 2017
Transcriptional dissection of melanoma identifies a high-risk subtype underlying TP53 family genes and epigenome deregulationBrateil Badal, Alexander Solovyov, Serena Di Cecilia, et al.
Pageof 16

Showing results (111-120 of 156) with videos related to

Sort By:
Pageof 16
Nature|August 25, 2016
HER2 expression identifies dynamic functional states within circulating breast cancer cellsNicole Vincent Jordan, Aditya Bardia, Ben S Wittner, et al.
Journal of the National Cancer Institute|June 5, 2020
Tumor Microenvironment Immune Response in Pancreatic Ductal Adenocarcinoma Patients Treated With Neoadjuvant TherapyTheodoros Michelakos, Lei Cai, Vincenzo Villani, et al.
Nature|July 6, 2012
RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasisMin Yu, David T Ting, Shannon L Stott, et al.
Science (New York, N.Y.)|February 8, 2020
Deregulation of ribosomal protein expression and translation promotes breast cancer metastasisRichard Y Ebright, Sooncheol Lee, Ben S Wittner, et al.
Journal for Immunotherapy of Cancer|April 3, 2026
TROP2/claudin program mediates immune exclusion to impede checkpoint blockade in breast cancerBogang Wu, Win Thant, Elena Bitman, et al.
Nature Communications|February 10, 2017
Expression of β-globin by cancer cells promotes cell survival during blood-borne disseminationYu Zheng, David T Miyamoto, Ben S Wittner, et al.
Nature|April 15, 2026
Author Correction: HER2 expression identifies dynamic functional states within circulating breast cancer cellsNicole Vincent Jordan, Aditya Bardia, Ben S Wittner, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2026
Dynamic monitoring of antibody drug conjugates targeting TROP2 or HER2 in breast cancer using circulating tumor cellsAvanish Mishra, Rachel O Abelman, Quinn Cunneely, et al.
Cancer Research|January 20, 2022
Differential Kinase Activity Across Prostate Tumor Compartments Defines Sensitivity to Target InhibitionNezihi Murat Karabacak, Yu Zheng, Taronish D Dubash, et al.
JCI Insight|May 5, 2017
Transcriptional dissection of melanoma identifies a high-risk subtype underlying TP53 family genes and epigenome deregulationBrateil Badal, Alexander Solovyov, Serena Di Cecilia, et al.
Pageof 16